2024
|
P/S
|
Antihistamines, nasal steroids, and nasal spray preparations for treatment of respiratory disorders |
|
Invention
|
Hpk1 inhibitor for use in the treatment of cancer. The present invention relates to a method of t... |
|
P/S
|
Pharmaceutical & medicinal preparations for treatment of psoriasis and skin conditions. |
|
P/S
|
Pharmaceutical and medicinal preparations for treatment of psoriasis and skin conditions. |
|
P/S
|
Pharmaceutical and medicinal preparations for the treatment of psoriasis and skin conditions. |
2023
|
P/S
|
Pharmaceutical preparations for the treatment of psoriasis in human beings; Medicated ointments f... |
|
Invention
|
Treatment of allergic rhinitis using a combination of mometasone and olopatadine.
The present in... |
|
Invention
|
Novel nasal spray assembling process. The invention relates to a novel process of assembling nasa... |
|
Invention
|
Dispensing device and pharmaceutical composition for the treatment of rhinitis.
A nasal dispensi... |
2022
|
Invention
|
Nebulization composition comprising tiotropium and its method of administration. |
|
P/S
|
Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihist... |
|
Invention
|
Pyrimidine compounds for use as map4k1 inhibitors.
The present disclosure is directed to compoun... |
|
Invention
|
Pyrimidine compounds for use as map4k1 inhibitors. The present disclosure is directed to compound... |
|
Invention
|
Treatment of allergic rhinitis using a combination of mometasone and olopatadine. The present inv... |
2021
|
P/S
|
Pharmaceuticals and medicinal preparations being antihistamines, nasal steroids, nasal spray prod... |
|
Invention
|
Polymorphic forms of a ror inhibiting compound and processes for its preparation.
The present in... |
|
Invention
|
Polymorphic forms of a rorγ inhibiting compound and processes for its preparation. The present in... |
|
P/S
|
Pharmaceutical preparations for the treatment of respiratory disease and disorder, not for the tr... |
|
P/S
|
Antihistamine, nasal steroid, nasal spray product, namely, nasal spray preparations for treatment... |
2020
|
Invention
|
An inhalable dry powder composition for pulmonary diseases.
The present invention relates to an ... |
|
Invention
|
An inhalable dry powder composition for pulmonary diseases. The present invention relates to an i... |
|
Invention
|
Nebulization composition comprising glycopyrrolate and arformoterol. The present invention relate... |
|
Invention
|
Pharmaceutical compositions comprising mupirocin. The present invention relates to a pharmaceutic... |
|
Invention
|
Nebulization composition comprising tiotropium and indacaterol.
This disclosure relates to a neb... |
|
Invention
|
Nebulization composition comprising tiotropium and indacaterol. This disclosure relates to a nebu... |
2019
|
Invention
|
Sterile compositions of indacaterol suitable for nebulization.
The present invention relates to ... |
|
Invention
|
Sterile compositions of indacaterol suitable for nebulization. The present invention relates to a... |
|
Invention
|
Topical composition comprising mupirocin. The present invention relates to a topical composition ... |
|
Invention
|
Nebulization composition comprising glycopyrrolate and formoterol. The present invention relates ... |
|
Invention
|
Nebulization composition of mometasone. The present invention relates to a sterile pharmaceutical... |
|
Invention
|
Tiotropium inhalation solution for nebulization. The present invention relates to a sterile pharm... |
|
Invention
|
Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopat... |
2018
|
Invention
|
Dispensing device and pharmaceutical composition for the treatment of rhinitis. A nasal dispensin... |
|
Invention
|
Label |
2017
|
Invention
|
Nebulized tiotropium. The present invention relates to therapeutic methods of administering tiotr... |
|
Invention
|
Nebulized tiotropium.
The present invention relates to therapeutic methods of administering tiot... |
|
Invention
|
Nebulizable compositions of tiotropium and formoterol. The present disclosure relates to a nebuli... |
|
Invention
|
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine.
The present ... |
|
Invention
|
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine. The present i... |
2016
|
Invention
|
Inhaler |